/Companies

Melio

16 known investors

Find your way into Melio

Sign up to see every warm intro you have to Melio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Melio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Melio develops a rapid bloodborne pathogen testing platform that identifies common pathogens from blood samples within hours, replacing traditional multi-day culture-based diagnostics.

Founders & leadership

MSMridu Sinha, PhD
Mridu Sinha, PhDCo-Founder and CEO
SF
Stephanie Fraley, PhDCo-Founder

Investors · 16

Also in the syndicate · 3

FiservleadFiserv, Inc.leadShopify Ventures

Funding

SEC filings, press & company announcements

$150M disclosed across 1 of 5 rounds · 2020–2024

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Melio do?
Melio develops a rapid bloodborne pathogen testing platform that identifies common pathogens from blood samples within hours, replacing traditional multi-day culture-based diagnostics.
Who founded Melio?
Melio was founded by Mridu Sinha, PhD, Stephanie Fraley, PhD.
Who are Melio's investors?
Melio's investors include Accel, Cove Fund, General Catalyst, Lexi Ventures, LongeVC, SOSV, Bessemer Venture Partners, Capital One Ventures and 5 more.
How much funding has Melio raised?
Melio has disclosed $150M raised across 1 of its 5 known rounds.